Lowey Dannenberg Notifies Rentokil Initial PLC (“Rentokil” or the “Company”) (NYSE: RTO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against Rentokil Initial PLC for alleged violations of federal securities laws, impacting investors who purchased shares during the specified Class Period [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit was initiated by Lowey Dannenberg P.C. on behalf of investors who acquired Rentokil common stock between December 1, 2023, and September 10, 2024 [1]. - The complaint alleges that Rentokil and its officers made false or misleading statements regarding the integration of Terminix, leading to significant operational challenges [2]. Allegations Against Rentokil - Key allegations include: - Disruptions in early pilots of the Terminix integration [2]. - Ongoing execution challenges that were self-inflicted [2]. - The integration plan for Terminix was jeopardized due to these challenges [2]. - Rentokil and Terminix remained separate entities, which negatively affected business operations and organic revenue growth in North America [2]. - Positive statements made by the defendants about the company's prospects were materially false and misleading [2]. Impact on Investors - Following the revelation of these issues, Rentokil's stock price declined sharply, resulting in significant financial losses for investors [3]. - Investors who suffered losses exceeding $200,000 are encouraged to participate in the lawsuit and must act before January 27, 2025, to serve as Lead Plaintiff [3].